Ascani is a seasoned financial executive with more than 40 years of leadership expertise across a wide variety of industries...
At Advancing AI 2026, MindWalk unveils the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, running on AMD Instinct...
Expanded collaboration grants Alamar commercial rights to utilize ALZpath's proprietary pTau217 antibody in blood-based diagnostic tests for clinical use...
The i-SIGHT2 pivotal trial is evaluating a noninvasive office-based bioelectric therapy for intermediate to advanced dry age-related macular degeneration. ...
ReConnex is designed to reduce operating room preparation time and variability in all-inside anterior cruciate ligament procedures. ...
The clearance expands the LifeLens Physiological Monitor beyond ECG acquisition to include respiratory, temperature, activity and gait parameters. ...
Rapid growth reflects seismic shift toward greater use of AI across the MedTech industry...
New virtual-first approach helps millions get faster, easier treatment for common conditions...
The cloud-based tool gives hospitals retrospective programme-level insights into kidney replacement therapy delivered in acute and critical care settings....
Data presented at ASPN demonstrate the AI model's ability to identify patients who may benefit from support, often before they recognize a problem themselves...
